A drug used to treat asthma and allergies can block a crucial protein produced by the virus SARS-CoV-2, and reduce viral replication in human immune cells, according to a new…
SYDNEY: Australia’s political leaders were set to hold an emergency meeting on Wednesday as cases of the Omicron coronavirus variant broke infection records and forced countries around to world to…
MUMBAI: The subject expert committee (SEC) under India’s drug regulator is expected to review the EUA applications of drug companies seeking approval for Merck’s antiviral pill, Molnupiravir, on Thursday. Several…
MUMBAI: Sun Pharma said on Thursday it is gearing up to introduce antiviral Covid-19 drug, molnupiravir under the brand Molxvir at “an economical price” in India. Other companies including Hetero,…
Washington: The US Food and Drug Administration is expected to evaluate the efficacy of Moderna and Johnson & Johnson’s third dose of Covid vaccines this week. The FDA’s Vaccines and…
CHICAGO: New data from Moderna Inc’s large Covid-19 vaccine trial shows that the protection it offers declines over time, supporting the case for booster doses, the company said in a…
Pfizer recently announced that Jade Dare (B7451050), a 26-week, randomised, double-blind, double-dummy, active-controlled, multi-center phase-III study, met its co-primary and key secondary efficacy endpoints. The study showed that abrocitinib was…
